X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

REPCO HOME vs INDOCO REMEDIES - Comparison Results

REPCO HOME    Change

Repco Home Finance Ltd or RHFL is a professionally managed housing finance company headquartered in Chennai, Tamil Nadu. Incorporated in April 2000 as a wholly owned subsidiary of the Repatriates Co-operative Finance and Development Bank Limited (Rep... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    REPCO HOME INDOCO REMEDIES REPCO HOME/
INDOCO REMEDIES
 
P/E (TTM) x 14.3 38.3 37.4% View Chart
P/BV x 2.8 3.0 93.4% View Chart
Dividend Yield % 0.4 0.8 51.9%  

Financials

 REPCO HOME   INDOCO REMEDIES
EQUITY SHARE DATA
    REPCO HOME
Mar-17
INDOCO REMEDIES
Mar-17
REPCO HOME/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs891360 247.3%   
Low Rs500249 200.5%   
Sales per share (Unadj.) Rs166.9119.0 140.2%  
Earnings per share (Unadj.) Rs29.18.4 348.3%  
Cash flow per share (Unadj.) Rs29.715.2 195.0%  
Dividends per share (Unadj.) Rs2.001.60 125.0%  
Dividend yield (eoy) %0.30.5 54.8%  
Book value per share (Unadj.) Rs181.870.7 257.1%  
Shares outstanding (eoy) m62.5692.15 67.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x4.22.6 162.7%   
Avg P/E ratio x23.936.4 65.5%  
P/CF ratio (eoy) x23.420.0 117.0%  
Price / Book Value ratio x3.84.3 88.8%  
Dividend payout %6.919.1 35.9%   
Avg Mkt Cap Rs m43,50428,083 154.9%   
No. of employees `0000.76.0 11.1%   
Total wages/salary Rs m4312,167 19.9%   
Avg. sales/employee Rs Th15,584.81,817.0 857.7%   
Avg. wages/employee Rs Th643.4359.0 179.2%   
Avg. net profit/employee Rs Th2,720.2127.7 2,130.4%   
INCOME DATA
Net Sales Rs m10,44210,968 95.2%  
Other income Rs m1740 43.1%   
Total revenues Rs m10,45911,007 95.0%   
Gross profit Rs m9,2831,565 593.3%  
Depreciation Rs m36633 5.6%   
Interest Rs m6,46362 10,407.6%   
Profit before tax Rs m2,802909 308.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m979139 706.0%   
Profit after tax Rs m1,823771 236.5%  
Gross profit margin %88.914.3 623.2%  
Effective tax rate %34.915.3 229.1%   
Net profit margin %17.57.0 248.4%  
BALANCE SHEET DATA
Current assets Rs m6,6985,725 117.0%   
Current liabilities Rs m21,4175,454 392.7%   
Net working cap to sales %-141.02.5 -5,711.4%  
Current ratio x0.31.0 29.8%  
Inventory Days Days062 0.0%  
Debtors Days Days072 0.0%  
Net fixed assets Rs m915,307 1.7%   
Share capital Rs m626184 339.4%   
"Free" reserves Rs m6,8036,331 107.5%   
Net worth Rs m11,3726,516 174.5%   
Long term debt Rs m55,3161,323 4,180.8%   
Total assets Rs m90,43311,970 755.5%  
Interest coverage x1.415.6 9.2%   
Debt to equity ratio x4.90.2 2,395.3%  
Sales to assets ratio x0.10.9 12.6%   
Return on assets %9.27.0 131.7%  
Return on equity %16.011.8 135.5%  
Return on capital %13.912.4 112.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m01,141 0.0%   
Net fx Rs m03,366 0.0%   
CASH FLOW
From Operations Rs m-10,008886 -1,129.1%  
From Investments Rs m-59-1,706 3.5%  
From Financial Activity Rs m10,0911,316 767.0%  
Net Cashflow Rs m24497 4.8%  

Share Holding

Indian Promoters % 37.3 59.2 63.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.5 12.5 132.0%  
FIIs % 30.1 6.0 501.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.2 22.4 72.3%  
Shareholders   12,020 12,805 93.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare REPCO HOME With:   EDELWEISS FINANCIAL  THOMAS COOK INDIA  REDINGTON (INDIA)  NESCO LIMITED  KITEX GARMENTS  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

REPCO HOME Announces Quarterly Results (1QFY19); Net Profit Up 34.9% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, REPCO HOME has posted a net profit of Rs 609 m (up 34.9% YoY). Sales on the other hand came in at Rs 3 bn (up 8.0% YoY). Read on for a complete analysis of REPCO HOME's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3% (Quarterly Result Update)

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

Revenge of the Ratings Agencies(Vivek Kaul's Diary)

Sep 7, 2018

Do you remember when ratings agencies ruled financial markets? Nick explains why he thinks it's time to prepare yourselves for a comeback of the ratings agencies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

REPCO HOME SHARE PRICE


Sep 19, 2018 (Close)

TRACK REPCO HOME

  • Track your investment in REPCO HOME with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

REPCO HOME - THOMAS COOK INDIA COMPARISON

COMPARE REPCO HOME WITH

MARKET STATS